Literature DB >> 28273771

Revisiting cognitive reserve and cognition in multiple sclerosis: A closer look at depression.

Viral P Patel1, Lisa As Walker2, Anthony Feinstein3.   

Abstract

BACKGROUND: The protective effect of cognitive reserve (CR) on cognition in people with multiple sclerosis (PwMS) has been well described.
OBJECTIVE: To explore the relationship between aspects of CR, namely, leisure pursuits and depression.
METHODS: In a cross-sectional study, a sample of 155 PwMS and 115 healthy controls (HC) underwent cognitive testing with the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS) battery. Leisure activity was retrospectively recorded using the Leisure Activity Scale (LAS). Depression was assessed using the Hospital Anxiety and Depression Scale.
RESULTS: PwMS demonstrated greater decreases in leisure activity over time compared to the HC group, particularly in the past year ( p < 0.001). Here, depression accounted for 17% of the variance in determining the level of leisure activity ( p < 0.001). Premorbid IQ and leisure activity within the past year emerged as significant predictors of information processing speed, learning, memory and executive function. After controlling for depression, the influence of leisure activity on cognition was insignificant.
CONCLUSION: Depression can cause significant changes in behaviour which can influence indices of CR, such as leisure pursuits. Successfully treating depression may lead to a more active lifestyle thereby offsetting in part the cognitive burden of disease.

Entities:  

Keywords:  Multiple sclerosis; cognition; cognitive reserve; depression

Mesh:

Year:  2017        PMID: 28273771     DOI: 10.1177/1352458517692887

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  7 in total

1.  Effect of Donepezil on Cognitive Impairment, Quality of Life, and Depression in Multiple Sclerosis Patients: A Randomized Clinical Trial.

Authors:  Mohammad Mahdi Shahpouri; Majid Barekatain; Mahgol Tavakoli; Shervin Badihian; Vahid Shaygannejad
Journal:  Int J Prev Med       Date:  2020-06-19

2.  Cognitive impairment and the regional distribution of cerebellar lesions in multiple sclerosis.

Authors:  Sean M Tobyne; Wilson B Ochoa; J Daniel Bireley; Victoria Mj Smith; Jeroen Jg Geurts; Jeremy D Schmahmann; Eric C Klawiter
Journal:  Mult Scler       Date:  2017-09-21       Impact factor: 6.312

3.  Can we predict cognitive decline after initial diagnosis of multiple sclerosis? Results from the German National early MS cohort (KKNMS).

Authors:  Andreas Johnen; Paul-Christian Bürkner; Nils C Landmeyer; Björn Ambrosius; Pasquale Calabrese; Jeremias Motte; Nicole Hessler; Gisela Antony; Inke R König; Luisa Klotz; Muna-Miriam Hoshi; Lilian Aly; Sergiu Groppa; Felix Luessi; Friedemann Paul; Björn Tackenberg; Florian Then Bergh; Tania Kümpfel; Hayrettin Tumani; Martin Stangel; Frank Weber; Antonios Bayas; Brigitte Wildemann; Christoph Heesen; Uwe K Zettl; Frauke Zipp; Bernhard Hemmer; Sven G Meuth; Ralf Gold; Heinz Wiendl; Anke Salmen
Journal:  J Neurol       Date:  2018-12-04       Impact factor: 4.849

4.  Functional and self-care capacity of people with multiple sclerosis.

Authors:  Ana Railka de Souza Oliveira-Kumakura; Larissa Maria Bezutti; Juliany Lino Gomes Silva; Renata Cristina Gasparino
Journal:  Rev Lat Am Enfermagem       Date:  2019-10-07

Review 5.  Neuropsychiatric and cognitive effects of the COVID-19 outbreak on multiple sclerosis patients.

Authors:  Fahimeh Haji Akhoundi; Mohammad Ali Sahraian; Abdorreza Naser Moghadasi
Journal:  Mult Scler Relat Disord       Date:  2020-04-29       Impact factor: 4.339

6.  Correlates of patient-reported cognitive performance with regard to disability.

Authors:  Delphine Van Laethem; Alexander De Cock; Jeroen Van Schependom; Ralph H B Benedict; Guy Nagels; Marie D'hooghe
Journal:  Sci Rep       Date:  2022-08-05       Impact factor: 4.996

7.  The Psychological Impact of COVID-19 Pandemic on People With Multiple Sclerosis.

Authors:  Francesco Motolese; Mariagrazia Rossi; Giuliano Albergo; Domenica Stelitano; Marialucia Villanova; Vincenzo Di Lazzaro; Fioravante Capone
Journal:  Front Neurol       Date:  2020-10-30       Impact factor: 4.003

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.